Next-gen blood testing to provide 1000x more data to pharma companies
Pharma and researchers lack rapid, high-dimensional biomolecule measurements from tiny blood samples to monitor dynamic protein changes over time.
SimpleScan is a microscale blood-testing platform that rapidly quantifies biomolecules from ~1 microliter samples to generate high-density proteomic readouts.
Pharmaceutical companies and biomedical researchers who need next-generation proteomic datasets and dynamic protein-expression monitoring.


